Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II

Status: Recruiting
Location: See all (6) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study is a prospective, single-arm, multicenter study to evaluate the safety and effectiveness of the Vertex Pulmonary Embolectomy System in participants presenting with clinical signs and symptoms of acute pulmonary embolism.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 79
Healthy Volunteers: f
View:

• Age ≥ 18 years \< 80 years

• Acute onset of symptoms ≤ 14 days consistent with the presence of pulmonary embolism.

• CTA evidence (site determined) of proximal PE (filling defect in at least one main or interlobar pulmonary artery)

• RV/LV ratio of \> 0.9 on CTA as assessed by investigator (site determined).

• Systolic blood pressure ≥ 90 mmHg (initial SBP may be ≥ 80 mmHg if the pressure recovers to ≥ 90 mmHg with fluids)

• Subject or subject's legally authorized representative (LAR) is willing and able to provide written informed consent prior to receiving any non-standard of care Protocol-specific procedures

• Subject is willing and able to comply with all Protocol-required follow-up visits

Locations
United States
Florida
Ascension Sacred Heart
RECRUITING
Pensacola
Louisiana
Cardiovascular Institute of the South
RECRUITING
Houma
North Carolina
University of North Carolina
RECRUITING
Chapel Hill
New York
Northwell Health
RECRUITING
Staten Island
Pennsylvania
UPMC
RECRUITING
Harrisburg
Texas
Baylor Scott & White
RECRUITING
Plano
Contact Information
Primary
Karlee Hunter
karlee@jupiterendo.com
7072914074
Backup
Aadi Chachad
Aadi@jupiterendo.com
Time Frame
Start Date: 2024-10-15
Estimated Completion Date: 2026-03
Participants
Target number of participants: 145
Treatments
Experimental: Vertex Pulmonary Embolectomy System
Patients presenting with clinical signs and symptoms of acute PE and who meet the study criteria will be treated with the Vertex Pulmonary Embolectomy System
Related Therapeutic Areas
Sponsors
Leads: Neptune Medical

This content was sourced from clinicaltrials.gov